Northern Trust Corp Veracyte, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 948,435 shares of VCYT stock, worth $37.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

948,435

Previous 930,910 1.88%

Holding current value

$37.5 Million

Previous $20.2 Million 60.0%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $368,025 - $617,756	17,525 Added 1.88%	948,435 $32.3 Million
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $670,887 - $837,720	-35,572 Reduced 3.68%	930,910 $20.2 Million
Q1 2024 May 14, 2024	SELL	$21.0 - $29.1 $279,615 - $387,466	-13,315 Reduced 1.36%	966,482 $21.4 Million
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $49,911 - $72,589	-2,531 Reduced 0.26%	979,797 $27 Million
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $6.04 Million - $8.09 Million	270,531 Added 38.01%	982,328 $21.9 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $586,460 - $755,180	27,980 Added 4.09%	711,797 $18.1 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $193,287 - $261,942	-9,392 Reduced 1.35%	683,817 $15.2 Million
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $1.74 Million - $3.41 Million	-113,909 Reduced 14.11%	693,209 $16.4 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $160,825 - $270,630	-9,700 Reduced 1.19%	807,118 $13.4 Million
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $979,329 - $1.87 Million	-63,387 Reduced 7.2%	816,818 $16.3 Million
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $138,485 - $268,323	6,312 Added 0.72%	880,205 $24.3 Million
Q4 2021 Feb 08, 2022	BUY	$36.09 - $53.79 $148,329 - $221,076	4,110 Added 0.47%	873,893 $36 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $546,482 - $812,665	-15,342 Reduced 1.73%	869,783 $40.4 Million
Q2 2021 Aug 13, 2021	SELL	$32.94 - $56.62 $1.89 Million - $3.25 Million	-57,478 Reduced 6.1%	885,125 $35.4 Million
Q1 2021 May 12, 2021	BUY	$44.47 - $81.38 $3.16 Million - $5.79 Million	71,100 Added 8.16%	942,603 $50.7 Million
Q4 2020 Feb 11, 2021	BUY	$32.49 - $61.88 $34,374 - $65,469	1,058 Added 0.12%	871,503 $42.7 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $1.74 Million - $2.32 Million	65,094 Added 8.08%	870,445 $28.3 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $1.18 Million - $1.7 Million	60,398 Added 8.11%	805,351 $20.9 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $2.21 Million - $4.14 Million	137,155 Added 22.57%	744,953 $18.1 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $251,604 - $363,118	-12,108 Reduced 1.95%	607,798 $17 Million
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $5.27 Million - $6.83 Million	220,869 Added 55.35%	619,906 $14.9 Million
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $1.19 Million - $1.54 Million	53,792 Added 15.58%	399,037 $11.4 Million
Q1 2019 May 13, 2019	SELL	$12.0 - $25.76 $7,716 - $16,563	-643 Reduced 0.19%	345,245 $8.64 Million
Q4 2018 Feb 12, 2019	SELL	$9.15 - $14.85 $51,734 - $83,961	-5,654 Reduced 1.61%	345,888 $4.35 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $784,780 - $1.04 Million	82,176 Added 30.51%	351,542 $3.36 Million
Q2 2018 Sep 18, 2018	SELL	$5.39 - $9.66 $11,976 - $21,464	-2,222 Reduced 0.82%	269,366 $2.52 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $2,856 - $5,119	530 Added 0.2%	271,588 $2.54 Million
Q1 2018 May 09, 2018	SELL	$5.44 - $6.97 $1,175 - $1,505	-216 Reduced 0.08%	271,058 $1.51 Million
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $18,271 - $28,297	-3,020 Reduced 1.1%	271,274 $1.77 Million
Q3 2017 Nov 13, 2017	BUY	$7.81 - $8.77 $2.14 Million - $2.41 Million	274,294	274,294 $2.41 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Veracyte, Inc. Transaction History